US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.550
  • 0.0000.00%
Close Dec 27 16:00 ET
  • 1.480
  • -0.070-4.52%
Post 19:22 ET
10.73MMarket Cap-1.08P/E (TTM)

Biorestorative Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biorestorative Therapies Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
350.00K
233.60K
-116.40K
Miss Est.
+1040.07%
+660.91%
-33.26%
EPS
-0.43
-0.13
+0.30
Beat Est.
+32.82%
-133.33%
+69.76%
Analyst Rating
Buy

Dec 28, 2024

Biorestorative Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 628.000K--
--2024/Q4-- / 475.000K--
Nov 13, 20242024/Q3233.600K / 350.000K--
Aug 13, 20242024/Q289.100K / 15.000K--
May 14, 20242024/Q135.000K / 15.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 628.000K--
--2024/Q4-- / 475.000K--
Nov 13, 20242024/Q3233.600K / 350.000K--
Aug 13, 20242024/Q289.100K / 15.000K--
May 14, 20242024/Q135.000K / 15.000K--

Unlock Free Earnings Estimates

Biorestorative Therapies Earnings Reports

  • Biorestorative Therapies | 8-K: BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 13 16:14 ET

  • Biorestorative Therapies | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:22 ET

  • Biorestorative Therapies | 10-K/A: Annual report (Amendment)

    Nov 6 16:28 ET

  • Biorestorative Therapies | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 28, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data